Trending in Gene & Cell Therapy: GS010 Approvals, ITVISMA and More
Автор: LucidQuest
Загружено: 2026-01-09
Просмотров: 1
Описание: In Gene and Cell Therapy news, GenSight’s GS010/LUMEVOQ® gains early access approval in Israel and compassionate use approval in France for ND4-LHON patients. ITVISMA, a gene therapy for SMA, is administered globally for the first time in Abu Dhabi. Zugo-cel CAR-T shows promising results in autoimmune diseases and B-cell malignancies. Sangamo submits a rolling BLA for ST-920 in Fabry disease, while Ultragenyx completes BLA submission for DTX401 in Glycogen Storage Disease. Major updates also include progress in Parkinson’s, TMA, and Rett Syndrome gene therapies.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: